Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Edward K. Chapnick is active.

Publication


Featured researches published by Edward K. Chapnick.


Infectious Disease Clinics of North America | 1996

Necrotizing soft-tissue infections.

Edward K. Chapnick; Elfatih I. M. Abter

Necrotizing soft-tissue infections may be rapidly fatal because of toxin-induced circulatory collapse. Because of the often nonspecific clinical presentation, prompt diagnosis may be difficult but is imperative as prompt treatment can be lifesaving. This article discusses necrotizing fasciitis and clostridial myonecrosis, and highlights pathogenesis, clinical presentation, diagnosis, and treatment.


Infectious Disease Clinics of North America | 1999

CONJUGATED POLYSACCHARIDE VACCINES

Hussain Ahmad; Edward K. Chapnick

The joining of polysaccharide antigens to various proteins can result in increased immunogenicity of vaccines composed of such antigens. This article discusses conjugated polysaccharide vaccines for Haemophilus influenzae, Streptococcus pneumoniae, and Neisseria meningitis. Increased availability and use of such vaccines may result in the ability to give more effective vaccines earlier in life, further reducing the incidence of diseases caused by these organisms.


Infection Control and Hospital Epidemiology | 1999

Bacitracin versus mupirocin for Staphylococcus aureus nasal colonization.

Norberto E. Soto; Ashok Vaghjimal; Annette Stahl-Avicolli; John R. Protic; Larry I. Lutwick; Edward K. Chapnick

We performed a randomized prospective study of 5-day treatment with topical mupirocin or bacitracin for the elimination of Staphylococcus aureus nasal colonization in healthcare workers (HCWs). Nasal cultures were obtained from 141 HCWs, 37 (26%) of whom showed S. aureus. After 72 to 96 hours of treatment, the organism was eradicated in 15 (94%) of 16 by mupirocin and in 8 (44%) of 18 by bacitracin (P = .0031). Similar efficacy was demonstrated at 30 days. Mupirocin may be more effective than bacitracin for eradication of S. aureus in healthy HCWs.


Infection Control and Hospital Epidemiology | 1996

Comparative killing kinetics of methicillin-resistant Staphylococcus aureus by bacitracin or mupirocin

Edward K. Chapnick; Jeremy D. Gradon; Barry N. Kreiswirth; Larry I. Lutwick; Benjamin C. Schaffer; Thomas D. Schiano; Michael H. Levi

The in vitro activities of bacitracin and mupirocin were compared for seven different strains of methicillin-resistant Staphylococcus aureus. Six of seven strains showed bacitracin minimum inhibitory concentrations (MICs) of 0.5 to 1.0 units/mL, and all seven had mupirocin MICs of 0.5 to 2 micrograms/mL. Time-kill studies revealed 2.6- to 4.5-log reduction in 24 hours with strains susceptible to bacitracin (4 units/mL) and 0 to 2.2 reduction with mupirocin (16 micrograms/mL). Bacitracin should be considered further for in vivo studies because of enhanced bacteriocidal effect and lower cost.


Annals of Pharmacotherapy | 1995

Paromomycin-associated pancreatitis in HIV-related cryptosporidiosis.

Winston W. Tan; Edward K. Chapnick; Elfatih I. M. Abter; Stephen Haddad; Eliot H. Zimbalist; Larry I. Lutwick

Objective: To report a case of pancreatitis related to paromomycin administration. Case summary: A 39-year-old man with AIDS developed pancreatitis concurrent with successful treatment of intestinal cryptosporidiosis with paromomycin. The hyperamylasemia resolved with discontinuation of the agent and recurred when paromomycin treatment was reinstituted. Discussion: To our knowledge, this is the first reported case of pancreatitis believed to be induced by paromomycin. Although pancreatitis in HIV-infected patients has multiple causes, the nature of this case suggests the involvement of paromomycin. The mechanism of action is unclear. Conclusions: Pancreatitis should be considered in the differential diagnosis of abdominal pain in patients who are treated with paromomycin.


Clinical Journal of The American Society of Nephrology | 2011

Spinal Epidural Abscess in Hemodialysis Patients: A Case Series and Review

San S. Wong; Smitha Daka; Andrew Pastewski; Win Kyaw; Edward K. Chapnick; Douglas V. Sepkowitz

Spinal epidural abscess (SEA) is a rare but potentially devastating condition. We noticed an increase in the number of cases of SEA, with the majority in hemodialysis (HD) patients. This prompted a retrospective chart review of all cases of SEA admitted from 2000 to 2005 and a literature search of similar cases. We identified 19 SEA cases treated at Long Island College Hospital during this 6-year period, of which six were on HD: four were dialyzed via catheter, one via arteriovenous fistula, and in one the method of dialysis was not documented. Four patients had bacteremia with Staphylococcus aureus. Four patients presented with paresis or paralysis; only one improved. The mortality rate was 33% (2/6). We found 30 other cases of SEA in patients on HD from the literature. These 36 HD cases were compared with 85 SEA cases that were not on HD (13 from our study and 72 described in two large case series). The mortality rate was noted to be much higher in HD patients (23% [6/26] versus 7% [6/85]). Neurologic deficit at presentation was noted in 47% (17/36) of HD patients versus 69% (59/85) of non-HD patients, but neurologic improvement was higher in non-HD patients (71% [42/59] versus 29% [5/17]). This is the largest literature review of SEA in patients on HD. When compared with non-HD patients, HD patients had a higher mortality rate and were less likely to improve neurologically.


Ophthalmic Surgery Lasers & Imaging | 2008

Endocapsular Cellulomonas as a Cause of Persistent Postoperative Endophthalmitis

Shobha Sharma; Norman Saffra; Tanyanyiwa Chinyadza; Monica Ghitan; Edward K. Chapnick

Sequestration of bacteria within the capsular fornices after cataract extraction with intraocular lens implantation can cause both acute and chronic inflammation. A case of persistent postoperative endophthalmitis caused by capsular sequestration of Cellulomonas is described. The patient underwent uncomplicated cataract extraction with intraocular lens implantation and subsequently developed acute postoperative endophthalmitis. Inflammation persisted despite several vitreous taps and the injection of intravitreal antibiotics. Definitive treatment required pars plana vitrectomy, intraocular lens explantation, capsular bag removal, and intravitreal and parenteral antibiotics. In patients with postoperative endophthalmitis, one must consider atypical organisms as the source and should consider explantation of the intraocular lens with capsular bag removal.


Southern Medical Journal | 2016

Does Alkaline Colonic pH Predispose to Clostridium difficile Infection

Purba Gupta; Stanley Yakubov; Kevin Tin; Diego Zea; Olga Garankina; Monica Ghitan; Edward K. Chapnick; Peter Homel; Yu Shia Lin; Michael M. Koegel

Objectives Clostridium difficile caused nearly 500,000 infections and was associated with approximately 29,000 deaths in 2011, according to data from the Centers for Disease Control and Prevention. C. difficile is a bacterium that causes diarrhea and, often, severe illness in healthcare facilities, as well as the community. Our objective was to determine whether alkaline colonic pH predisposes to colonization and infection with C. difficile. Methods A total of 228 patients with diarrhea and/or abdominal pain, leukocytosis, and fever were included. Stool pH was measured, and C. difficile antigen and toxin in stool were detected. Results Of 228 patients, 30 (13.2%) tested positive for C. difficile (antigen+/toxin+) and 171 (75%) were C. difficile negative (antigen−/toxin−). Of 171 patients who tested negative, 93 (54.4%) had stool pH >7.0 and 78 (45.6%) had pH ⩽7.0. Among the 30 patients who tested positive, 26 (86.7%) had stool pH >7.0 (P = 0.002). Among the 27 colonized patients (antigen+/toxin−), 12 (44.4%) had stool pH >7.0 (P = 0.34). For all patients with stool pH ⩽7.0, 96% tested negative for C. difficile infection (P = 0.002). Conclusions A strong association between C. difficile infection and alkaline stool pH was found.


Infectious Diseases in Clinical Practice | 2006

Fluconazole as an Antifungal Genitourinary Irrigant

Venkata K. Marella; Monica Ghitan; Edward K. Chapnick; Gilbert J. Wise

Abstract: Persistent funguria may cause significant morbidity and potential mortality. Both amphotericin B as a urinary irrigant and systemic fluconazole have been effective therapeutic agents. In cases when amphotericin supplies are limited by manufacturing shortfall or when renal insufficiency lessens urine levels of fluconazole, other antifungal treatment modalities may be necessary. Fluconazole used as a genitourinary irrigant has been reported as an effective antifungal bladder irrigant. In this study, 6 patients were treated with fluconazole bladder irrigant. Four patients had a complete response, 1 patient required a second course of treatment, and 1 patient did not respond. Further study is necessary to determine whether fluconazole is effective in the management of candiduria caused by non-albicans species. Amphotericin B should remain in the armamentarium of the treating physician. Present-day drug costs are comparable.


Ophthalmic Surgery Lasers & Imaging | 2010

Endogenous Fungal Endophthalmitis After Cardiac Surgery

Norman Saffra; Rajen U. Desai; Carly Seidman; Edward K. Chapnick

The authors present a single-patient interventional case report of endogenous fungal endophthalmitis (EFE) in a patient with an implanted prosthetic device. A 74-year-old man underwent a double coronary artery bypass graft with a bioprosthetic pericardial valve and transvenous dual chamber pacemaker. Four months later, he presented with EFE. Despite aggressive local and systemic antifungal therapy, the patient died of septic shock due to a fungally infected pacemaker. Successful management of post-cardiac surgery EFE requires aggressive local and systemic antifungal therapy, but without surgical removal of implanted thoracic hardware these modalities alone may be insufficient for a cure.

Collaboration


Dive into the Edward K. Chapnick's collaboration.

Top Co-Authors

Avatar

Monica Ghitan

Maimonides Medical Center

View shared research outputs
Top Co-Authors

Avatar

Yu Shia Lin

Maimonides Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ceres T. Tiu

Maimonides Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nitin Bhanot

Allegheny General Hospital

View shared research outputs
Top Co-Authors

Avatar

Ankur Lodha

Maimonides Medical Center

View shared research outputs
Top Co-Authors

Avatar

Norman Saffra

Maimonides Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge